Literature DB >> 28127715

The optimal treatment of patients with mild and moderate acute cholecystitis: time for a revision of the Tokyo Guidelines.

Charlotte S Loozen1, Maaike M Blessing2, Bert van Ramshorst2, Hjalmar C van Santvoort2, Djamila Boerma2.   

Abstract

INTRODUCTION: According to the Tokyo Guidelines, severity of acute cholecystitis is divided into three grades based on the degree of inflammation and the presence of organ dysfunction. These guidelines recommend grade I (mild) acute cholecystitis to be treated with early laparoscopic cholecystectomy and grade II (moderate) acute cholecystitis with delayed cholecystectomy. Yet, several studies have shown that, for acute cholecystitis in general, early cholecystectomy is superior to delayed cholecystectomy in terms of complication rate, duration of hospital stay and costs. The aim of this study was to determine the clinical outcomes of emergency cholecystectomy in patients with grade II acute cholecystitis. Based on our findings, we propose a revision of the Tokyo Guidelines.
METHODS: We performed a retrospective observational cohort study of 589 consecutive patients undergoing emergency cholecystectomy for acute calculous cholecystitis in a large teaching hospital between January 2002 and January 2015. Patients were classified according to the severity assessment criteria of the Tokyo Guidelines. Patients with grade I and grade II acute cholecystitis were compared for perioperative outcomes.
RESULTS: Emergency cholecystectomy was performed in 270 patients with grade I acute cholecystitis and 187 patients with grade II acute cholecystitis. There was no difference in conversion rate (6 vs. 6%, p = 0.985) and operating time (60 min [25-255] vs. 70 min [30-255], p = 0.421). Also the perioperative complication rate (7 vs. 9%, p = 0.517), 30-day mortality (1 vs. 1%, p = 0.648) and length of hospital stay (4 days [1-42] vs. 4 days [1-62], p = 0.327) were similar between grade I and grade II acute cholecystitis.
CONCLUSION: The clinical outcomes of emergency cholecystectomy did not differ between patients with grade I and grade II acute cholecystitis. The findings support a revision of the Tokyo Guidelines with respect to the recommendation of performing emergency cholecystectomy in both grade I and grade II acute cholecystitis.

Entities:  

Keywords:  Acute cholecystitis; Emergency cholecystectomy

Mesh:

Year:  2017        PMID: 28127715     DOI: 10.1007/s00464-016-5412-x

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  16 in total

1.  Who should perform laparoscopic cholecystectomy? A 10-year audit.

Authors:  A P Boddy; J M H Bennett; S Ranka; M Rhodes
Journal:  Surg Endosc       Date:  2007-05-05       Impact factor: 4.584

2.  Index cholecystectomy in grade II and III acute calculous cholecystitis is feasible and safe.

Authors:  Deepali Kamalapurkar; Tony C Y Pang; Mehan Siriwardhane; Michael Hollands; Emma Johnston; Henry Pleass; Arthur Richardson; Vincent W T Lam
Journal:  ANZ J Surg       Date:  2015-02-02       Impact factor: 1.872

Review 3.  Clinical practice. Acute calculous cholecystitis.

Authors:  Steven M Strasberg
Journal:  N Engl J Med       Date:  2008-06-26       Impact factor: 91.245

Review 4.  Early laparoscopic cholecystectomy is superior to delayed acute cholecystitis: a meta-analysis of case-control studies.

Authors:  Amy M Cao; Guy D Eslick; Michael R Cox
Journal:  Surg Endosc       Date:  2015-07-03       Impact factor: 4.584

5.  Prevalence and ethnic differences in gallbladder disease in the United States.

Authors:  J E Everhart; M Khare; M Hill; K R Maurer
Journal:  Gastroenterology       Date:  1999-09       Impact factor: 22.682

6.  Background: Tokyo Guidelines for the management of acute cholangitis and cholecystitis.

Authors:  Tadahiro Takada; Yoshifumi Kawarada; Yuji Nimura; Masahiro Yoshida; Toshihiko Mayumi; Miho Sekimoto; Fumihiko Miura; Keita Wada; Masahiko Hirota; Yuichi Yamashita; Masato Nagino; Toshio Tsuyuguchi; Atsushi Tanaka; Yasutoshi Kimura; Hideki Yasuda; Koichi Hirata; Henry A Pitt; Steven M Strasberg; Thomas R Gadacz; Philippus C Bornman; Dirk J Gouma; Giulio Belli; Kui-Hin Liau
Journal:  J Hepatobiliary Pancreat Surg       Date:  2007-01-30

7.  TG13 flowchart for the management of acute cholangitis and cholecystitis.

Authors:  Fumihiko Miura; Tadahiro Takada; Steven M Strasberg; Joseph S Solomkin; Henry A Pitt; Dirk J Gouma; O James Garden; Markus W Büchler; Masahiro Yoshida; Toshihiko Mayumi; Kohji Okamoto; Harumi Gomi; Shinya Kusachi; Seiki Kiriyama; Masamichi Yokoe; Yasutoshi Kimura; Ryota Higuchi; Yuichi Yamashita; John A Windsor; Toshio Tsuyuguchi; Toshifumi Gabata; Takao Itoi; Jiro Hata; Kui-Hin Liau
Journal:  J Hepatobiliary Pancreat Sci       Date:  2013-01       Impact factor: 7.027

8.  Assessing clinical outcomes of patients with acute calculous cholecystitis in addition to the Tokyo grading: a retrospective study.

Authors:  Wei-Chun Cheng; Yen-Cheng Chiu; Chiao-Hsiung Chuang; Chiung-Yu Chen
Journal:  Kaohsiung J Med Sci       Date:  2014-06-27       Impact factor: 2.744

9.  Acute cholecystitis in high risk surgical patients: percutaneous cholecystostomy versus laparoscopic cholecystectomy (CHOCOLATE trial): study protocol for a randomized controlled trial.

Authors:  Kirsten Kortram; Bert van Ramshorst; Thomas L Bollen; Marc G H Besselink; Dirk J Gouma; Tom Karsten; Philip M Kruyt; Grard A P Nieuwenhuijzen; Johannes C Kelder; Ellen Tromp; Djamila Boerma
Journal:  Trials       Date:  2012-01-12       Impact factor: 2.279

Review 10.  Laparoscopic cholecystectomy for acute cholecystitis: early or delayed?: Evidence from a systematic review of discordant meta-analyses.

Authors:  Guo-Min Song; Wei Bian; Xian-Tao Zeng; Jian-Guo Zhou; Yong-Qiang Luo; Xu Tian
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

View more
  1 in total

Review 1.  GI Surgical Emergencies: Scope and Burden of Disease.

Authors:  Matthew C Hernandez; Firas Madbak; Katherine Parikh; Marie Crandall
Journal:  J Gastrointest Surg       Date:  2018-10-15       Impact factor: 3.452

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.